The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

drug resistance

Oct 11, 2012

Ive became rsistance to virramune and was wondering can i take another medication in the same class as virramine

Response from Dr. Young

Hello and thanks for posting.

The answer depends on what drug resistance mutations your virus has accumulated. While resistance to nevirapine is often associated with resistance to other NNRTIs, some NNRTI-resistant virus retain susceptibility to the newer NNRTI etravirine.

According to the USCF InSite: Resistance to etravirine is associated with the selection of 1 or more of several resistance mutations. Clinical data in NNRTI-naive patients are needed to characterize de novo etravirine resistance. In patients with preexisting NNRTI resistance mutations and virologic failure on etravirine, a number of NNRTI mutations emerged, most commonly L100I, E138G, V179F V179I, Y181C Y181I, and H221Y; these were associated with decreased susceptibility to etravirine.

Switch out epivir for emtriva
switching medication

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint